Autism spectrum disorder (ASD) is thought to emerge during early cortical development.
However, the exact developmental stages and associated molecular networks that prime …

Sporadic Alzheimer's disease (AD) exclusively affects elderly people. Using direct
conversion of AD patient fibroblasts into induced neurons (iNs), we generated an age-equivalent …

Bipolar disorder (BD) is a psychiatric condition characterized by depressive and manic
episodes that affect 2% of the world population. The first-line long-term treatment for mood …

Mutations in the KCNT1 (Slack, K Na 1.1) sodium-activated potassium channel produce
severe epileptic encephalopathies. Expression in heterologous systems has shown that the …

Despite widespread interest in using human induced pluripotent stem cells (hiPSCs) in
neurological disease modeling, a suitable model system to study human neuronal connectivity is …

Personalized medicine has become increasingly relevant to many medical fields, promising
more efficient drug therapies and earlier intervention. The development of personalized …

Monoclonal antibodies (mAbs) hold promise in treating Parkinson's disease (PD), although
poor delivery to the brain hinders their therapeutic application. In the current study, it is …

Several mutations that cause Parkinson’s disease (PD) have been identified over the past
decade. These account for 15–25% of PD cases; the rest of the cases are considered sporadic…

Mutations in the IQSEC2 gene are associated with drug-resistant, multifocal infantile and
childhood epilepsy; autism; and severe intellectual disability (ID). We used induced pluripotent …

Autism spectrum disorders (ASDs) include a wide range of neurodevelopmental disorders.
Several reports showed that mutations in different high‐risk ASD genes lead to ASD. However…